Skip to main content
Clinical Trials/NCT05560867
NCT05560867
Terminated
Not Applicable

Neural Mechanisms of Motor Recovery With Technology Assisted Training for Post-stroke Hemiparesis

University of Maryland, Baltimore1 site in 1 country4 target enrollmentDecember 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemiparesis
Sponsor
University of Maryland, Baltimore
Enrollment
4
Locations
1
Primary Endpoint
Changes in cortical connectivity measures as assessed using fNIRS
Status
Terminated
Last Updated
last year

Overview

Brief Summary

Stroke is a leading cause of disability that often impairs arm function and activities of daily living. The costs of rehabilitation are significant and practical constraints often limit therapy to the first few months after stroke. However many studies have shown that patients in the later stages post-stroke can still continue to benefit from rehabilitation. Technology-assisted therapy may offer a means to efficiently provide ongoing therapies to patients in the later stages (>6 months) post-stroke. This study will determine which patients are best able to benefit from this therapy approach, and will also expand our knowledge of which brain structures need to be intact for patients to benefit from technology-assisted training. The results of this study will help to improve rehabilitation and quality of life for disabled Americans.

Detailed Description

Study Description: This study will investigate the neural mechanisms of technology-assisted-training for post-stroke hemiparesis by using functional near-infrared-spectroscopy (fNIRS). Patients with hemiparesis affecting the arm will be brought in for 3 weeks of technology-assisted-training while having fNIRS recordings of their brain activity. Analysis of these brain activation patterns will help determine what areas of the brain are necessary to respond to this type of training. Objectives: 1) to investigate brain network activity changes that occur during technology-assisted-training and 2) to determine the baseline residual brain network connectivity required for patients to respond to robot-assisted-training. Endpoints: The study will evaluate increases in cortical connectivity between bilateral primary motor areas, angular gyrus and parietal operculum to test the hypothesis that cortical connectivity in these areas will positively correlate with improvement in technology-assisted-assessments. The study will also assess baseline connectivity of the angular gyrus and parietal operculum to sensorimotor networks to test the hypothesis that cortical connectivity in these areas will predict reductions in arm motor impairments that occur with technology-assisted-training. Study Population: Patients of either gender with chronic (at least 6 months or more) hemiparesis of the arm caused by a single unilateral stroke will be recruited from Baltimore city and the surrounding counties.

Registry
clinicaltrials.gov
Start Date
December 14, 2022
End Date
May 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Robynne Braun, MD, PhD

Assistant Professor, Department of Neurology

University of Maryland, Baltimore

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 88 years
  • Able to provide informed consent based on Evaluation to Sign Informed Consent.
  • History of clinically defined, unilateral hemiparetic stroke, with radiologic exclusion of other possible diagnosis, causing weakness in 1 arm 6 months or more prior to enrollment.
  • Fugl-Meyer upper extremity score \<= 50 at time of enrollment
  • Medically stable to participate in the study and have mobility, visual, and cognitive abilities sufficient to follow directions and engage in the gamified therapeutic tasks.

Exclusion Criteria

  • Undergoing any significant medical treatments requiring regular visits, treatments, or therapies at the time of enrollment or anytime during the study.
  • Hair or scalp implant that would not allow near infrared spectroscopy probes to sit on scalp.
  • Injection of botulinum toxin to the paretic arm within 3 months of enrollment or during the study or injection of daxibotulinumtoxinA within 6 months of enrollment or during the study
  • Orthopedic, rheumatologic, or other medical disease that would make the procedures of participation dangerous, painful, or uncomfortable.
  • Contraindications to MRI, including intracranial magnetic items, implanted pumps, pacemakers, or stimulators, or claustrophobia.

Outcomes

Primary Outcomes

Changes in cortical connectivity measures as assessed using fNIRS

Time Frame: Baseline fNIRS collected at the time of study enrollment, with repeated fNIRS measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment)

Cortical connectivity is assessed between bilateral primary motor areas, angular gyrus and parietal operculum.

Changes in cortical connectivity measures as assessed using MRI

Time Frame: Baseline MRI will be collected at the time of study enrollment (for a total of up to 4 weeks during study enrollment)

Cortical connectivity is assessed between bilateral primary motor areas, angular gyrus and parietal operculum. MRI sequences include T1 MPRAGE, BOLD (T2\*), FLAIR T2, ASL, and DTI.

Secondary Outcomes

  • Changes in Fugl-Myer Scores for the Upper Extremity ("FM-UE")(At the time of enrollment with repeated measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment))
  • Changes in Wolf Motor Function Test ("WMFT")(At the time of enrollment (pre-training) with a second measure at the final study session (post-training) (for a total of up to 4 weeks during study enrollment).)
  • Changes in Stroke Impact Scale ("SIS")(At the time of enrollment (pre-training) with a second measure at the final study session (post-training) (for a total of up to 4 weeks during study enrollment))
  • Changes in arm kinematics (acceleration)(Baseline kinematics at the time of study enrollment with repeated measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment))
  • Changes in Shoulder Abduction Finger Extension ("SAFE") score(At the time of enrollment with repeated measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment))
  • Changes in NIH Stroke Scale Score ("NIHSS")(At the time of enrollment with repeated measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment))
  • Changes in arm kinematics (position)(Baseline kinematics at the time of study enrollment with repeated measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment))
  • Changes in arm kinematics (velocity)(Baseline kinematics at the time of study enrollment with repeated measures at each therapy treatment session (for a total of up to 4 weeks during study enrollment))
  • Changes in Action Research Arm Test(At the time of enrollment (pre-training) with a second measure at the final study session (post-training) (for a total of up to 4 weeks during study enrollment).)

Study Sites (1)

Loading locations...

Similar Trials